[go: up one dir, main page]

NO20025151L - Nye forbindelser - Google Patents

Nye forbindelser

Info

Publication number
NO20025151L
NO20025151L NO20025151A NO20025151A NO20025151L NO 20025151 L NO20025151 L NO 20025151L NO 20025151 A NO20025151 A NO 20025151A NO 20025151 A NO20025151 A NO 20025151A NO 20025151 L NO20025151 L NO 20025151L
Authority
NO
Norway
Prior art keywords
new connections
polypeptides
polynucleotides
methods
set forth
Prior art date
Application number
NO20025151A
Other languages
English (en)
Norwegian (no)
Other versions
NO20025151D0 (no
Inventor
Pankaj Agarwal
Paul R Murdock
Safia K Rizvi
Randall F Smith
Zhaoying Xiang
Karen S Kabnic
Ying-Ta Lai
Qing Xie
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20025151D0 publication Critical patent/NO20025151D0/no
Publication of NO20025151L publication Critical patent/NO20025151L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Reproductive Health (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Pain & Pain Management (AREA)
  • General Engineering & Computer Science (AREA)
NO20025151A 2000-04-27 2002-10-25 Nye forbindelser NO20025151L (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US19996300P 2000-04-27 2000-04-27
US20333600P 2000-05-11 2000-05-11
US20708700P 2000-05-25 2000-05-25
US20754600P 2000-05-26 2000-05-26
PCT/US2001/013360 WO2001081363A1 (fr) 2000-04-27 2001-04-26 Nouveaux composes

Publications (2)

Publication Number Publication Date
NO20025151D0 NO20025151D0 (no) 2002-10-25
NO20025151L true NO20025151L (no) 2002-12-13

Family

ID=27498358

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20025151A NO20025151L (no) 2000-04-27 2002-10-25 Nye forbindelser

Country Status (15)

Country Link
EP (1) EP1276755A4 (fr)
JP (1) JP2003530869A (fr)
KR (1) KR20030032940A (fr)
CN (1) CN1439017A (fr)
AU (1) AU2001257265A1 (fr)
BR (1) BR0110402A (fr)
CA (1) CA2407449A1 (fr)
CZ (1) CZ20023548A3 (fr)
HK (1) HK1053840A1 (fr)
HU (1) HUP0300595A3 (fr)
IL (1) IL152416A0 (fr)
MX (1) MXPA02010692A (fr)
NO (1) NO20025151L (fr)
PL (1) PL358580A1 (fr)
WO (1) WO2001081363A1 (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use
US6558936B1 (en) * 1999-10-01 2003-05-06 Millennium Pharmaceuticals, Inc. Human lipase proteins, nucleic acids encoding them, and uses of both of these
US6630335B1 (en) 2000-02-11 2003-10-07 Millennium Pharmaceuticals, Inc. 14171 protein kinase, a novel human protein kinase and uses thereof
NZ523122A (en) * 2000-06-22 2004-06-25 Smithkline Beecham Corp Polypeptides and polynucleotides and methods of identifying agonists and antagonists in relation to treatment of diseases
US20030211515A1 (en) * 2000-06-30 2003-11-13 Lasek Amy K Novel compounds
US6924364B2 (en) 2000-08-04 2005-08-02 Zymogenetics, Inc. Human secreted protein, Zzp1
US7358353B2 (en) 2000-08-22 2008-04-15 Agensys, Inc. Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
ES2395524T3 (es) 2000-08-22 2013-02-13 Agensys, Inc. Acido nucleico y proteina correspondiente denominada 158P1D7 util para el tratamiento y la detección del cancer de vejiga y otros canceres
AU1181802A (en) 2000-09-27 2002-04-08 Curagen Corp Novel proteins and nucleic acids encoding same
WO2002026826A2 (fr) * 2000-09-27 2002-04-04 Curagen Corporation Nouvelles proteines et acides nucleiques codant pour celles-ci
EP1339847A2 (fr) * 2000-11-28 2003-09-03 Amgen, Inc. Molecules associees au facteur de croissance transformant-beta et leurs applications
JP2004535161A (ja) 2001-03-08 2004-11-25 イミュネックス・コーポレーション ヒト・セルピン・ポリペプチド
US6921807B2 (en) 2001-03-29 2005-07-26 Zymogenetics, Inc. Proteinase inhibitor ZSERP9
US7033790B2 (en) 2001-04-03 2006-04-25 Curagen Corporation Proteins and nucleic acids encoding same
US20020172995A1 (en) * 2001-05-17 2002-11-21 Wei Shao Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
WO2003004527A2 (fr) * 2001-07-06 2003-01-16 Nsgene A/S Nouveaux facteurs neurotrophiques
US20030215852A1 (en) * 2002-04-01 2003-11-20 Wyeth Novel pancortin-Pablo protein interactions and methods of use thereof
AU2004210975B2 (en) * 2003-02-10 2008-04-10 Agensys, Inc. Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
US7422906B2 (en) 2003-02-10 2008-09-09 Taisho Pharmaceutical Co., Ltd. Apoptosis-inducing gene and utilization of the same
CA2534353A1 (fr) * 2003-08-01 2005-02-10 Zymogenetics, Inc. Proteine zacrp11 liee au complement d'adipocyte
US7399469B2 (en) 2004-03-26 2008-07-15 Pdl Biopharma, Inc. Anti-LFL2 antibodies for the diagnosis, prognosis and treatment of cancer
PT2887959T (pt) 2012-08-23 2019-02-01 Seattle Genetics Inc Conjugados anticorpo-fármaco (adc) que se ligam a proteínas 158p1d7
CA3009127A1 (fr) * 2016-01-06 2017-07-13 Yeda Research And Development Co. Ltd. Compositions et methodes pour le traitement d'affections malignes, autoimmunes et inflammatoires
CN108178797B (zh) * 2017-12-29 2020-12-01 西南大学 一种抗家蚕BmSRC多克隆抗血清、制备方法及应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830744A (en) * 1995-06-06 1998-11-03 Human Genome Sciences, Inc. Gene encoding human Dnase
JPH09512715A (ja) * 1994-05-05 1997-12-22 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ヒトｄｎａｓｅ
AU3395900A (en) * 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides

Also Published As

Publication number Publication date
KR20030032940A (ko) 2003-04-26
HUP0300595A2 (hu) 2003-06-28
NO20025151D0 (no) 2002-10-25
MXPA02010692A (es) 2003-03-10
CN1439017A (zh) 2003-08-27
CZ20023548A3 (cs) 2003-05-14
WO2001081363A1 (fr) 2001-11-01
EP1276755A4 (fr) 2004-03-31
CA2407449A1 (fr) 2001-11-01
HK1053840A1 (zh) 2003-11-07
AU2001257265A1 (en) 2001-11-07
JP2003530869A (ja) 2003-10-21
IL152416A0 (en) 2003-05-29
BR0110402A (pt) 2003-02-11
HUP0300595A3 (en) 2007-06-28
EP1276755A1 (fr) 2003-01-22
PL358580A1 (en) 2004-08-09

Similar Documents

Publication Publication Date Title
NO20025151L (no) Nye forbindelser
NO20090955L (no) BASB029-polynukleotid(er) og -polypeptider fra Neisseria meningitidis
ATE490466T1 (de) Als interne funktionskontrolle in tests zum nachweis von seltenen zellen verwendete markierte zellen
WO2002002636A3 (fr) Proteine zupar i associee a une membrane
NO20055634L (no) Fremgangsmate og arkitektur for a aksessere et internettprotokollmedia undersystem (IMS) over et tradlost lokalt nettverk (WLAN)
NO20062201L (no) Fremgangsmater og apparater for soking etter signalbaerere
WO2002090520A3 (fr) Proteine adaptatrice receptrice de la toll/interleukine-1 (tirap)
NO20026242D0 (no) Syntesemetoder for aplidin og nye antitumorale derivater, metoder for fremstilling og anvendelse av disse
MXPA03000227A (es) Compuestos novedosos.
DK1651247T3 (da) Behandling og diagnose af neoplasmer ved anvendelse af Thymic Stromal Lymphopoietin
WO2001072961A3 (fr) Nouveaux composes
NO20005952L (no) Antigene polypeptider fra Neisseria Meningitidis, tilsvarende polynukleotider og beskyttende antistoffer
DK1112366T3 (da) Polynucleotider og polypeptider BASB033 fra Neisseria Meningitidis samt deres anvendelser
DK1163343T3 (da) Neisseria meningitidis antigene polypeptider, tilsvarende polynukleotider og beskyttende antistoffer
DE60117788D1 (de) Menschliche wingless-änhliche gene
DE602004031355D1 (de) Neue 1,3-disubstituierte azetidinderivate zur verwendung als liganden des 5ht2a-rezeptors
GB2406913A (en) Stimulating and recording device
WO2002004600A3 (fr) Nouveaux composes
NO20016340L (no) Hodetraumeindusert cytoplasmatisk kalsiumbindende protein
NO20053511L (no) Nye fibrillin-liknende polypeptider
DK1257573T3 (da) Hidtil ukendt transskriptionsfaktor CARP-2
AU4567300A (en) Novel compounds
DE60140006D1 (de) Polypeptide aus haemophilus influenza
DK1309690T3 (da) MFQ-111, et humant GTPase-lignende protein
NO20053514L (no) Nye fibulinliknende polypeptider

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application